Linked Life Data

17096915

Source:http://linkedlifedata.com/resource/pubmed/id/17096915

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2006-11-13
pubmed:abstractText
To investigate the difference of serum interleukin-6 level in the patients with multiple myeloma (MM) of Vighur nationality and Han nationality and its clinical significance, the activity of serum interleukin-6 was detected in 80 patients with MM (33 Vighur patients, 47 Han patients) and 30 normal subjects as control by using sandwich ELISA with double antibody. The results showed that there was significant difference in serum interleukin-6 level between Vighur patients and Han patients (P < 0.01). The serum interleukin-6 level of patients with multiple myeloma was significantly higher than that of nomal control (P < 0.01). The serum interleukin-6 level of MM patients in second and third stage were also signifivantly higher than that of patients in first stage (P < 0.05). It is concluded that there was significant difference in the serum interleukin-6 level between Vighur patients and Han patients. The serum interleukin-6 level can be considered as one of indexes to judge the patient severity and the prognosis, also as one of comprehensive multiparameters to evaluate the curative efficiency and guide the clinical application of drugs.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1009-2137
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1038-9
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
[Detection of serum interleukin-6 level in patients with multiple myeloma of Vighur nationality and Han nationality and its clinical significance].
pubmed:affiliation
Department of Hemotology, Xinjiang Vighur Autonomous Region People Hospital, Urumqi 830001, China.
pubmed:publicationType
Journal Article, English Abstract